Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15.4B | $15.4B | $14.4B | $3.4B | $3.5B | |
| Gross Profit | $10.8B | $11.1B | $10.7B | $2.4B | $2.6B | |
| Operating Income | $1.1B | $1.5B | $1.1B | $205M | $231M | |
| EBITDA | $1.9B | $2.3B | $1.9B | $409M | $427M | |
| Diluted EPS | $1.52 | $0.56 | -$2.58 | -$0.43 | $0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.5B | $8.9B | $8.6B | $7.2B | $6.7B | |
| Total Assets | $21.6B | $20B | $22.7B | $21.3B | $19.3B | |
| Current Liabilities | $5.3B | $5.3B | $5.9B | $5.5B | $5.1B | |
| Total Liabilities | $14.6B | $13.7B | $16.5B | $16.2B | $15.4B | |
| Total Equity | $7B | $6.3B | $6.2B | $5.1B | $3.9B | |
| Total Debt | $7.6B | $7.2B | $9.8B | $9.6B | $9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2B | $2.1B | $1.6B | -$670M | -$340M | |
| Cash From Investing | -$3.5B | -$1.6B | -$600M | -$160M | -$116M | |
| Cash From Financing | $1.7B | -$1.3B | -$1.1B | -$226M | -$239M | |
| Free Cash Flow | -$1.5B | $1.3B | $1B | -$811M | -$436M | |
The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.
In the current month, EL has received 6 Buy ratings 16 Hold ratings, and 1 Sell ratings. The EL average analyst price target in the past 3 months is $104.30.
According to analysts, the consensus estimate is that The Estée Lauder Companies, Inc. share price will drop to $104.30 per share over the next 12 months.
Analysts are divided on their view about The Estée Lauder Companies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Estée Lauder Companies, Inc. is a Sell and believe this share price will rise from its current level to $65.00.
The price target for The Estée Lauder Companies, Inc. over the next 1-year time period is forecast to be $104.30 according to 23 Wall Street analysts, 6 of them rate the stock a Buy, 1 rates the stock a Sell, and 16 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for The Estée Lauder Companies, Inc. is a Hold. 16 of 23 analysts rate the stock a Hold at this time.
You can purchase shares of The Estée Lauder Companies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Estée Lauder Companies, Inc. shares.
The Estée Lauder Companies, Inc. was last trading at $107.48 per share. This represents the most recent stock quote for The Estée Lauder Companies, Inc.. Yesterday, The Estée Lauder Companies, Inc. closed at $107.48 per share.
In order to purchase The Estée Lauder Companies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.